NCT01711242View on ClinicalTrials.gov

Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

208

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2021

Conditions

Gastric Cancer

Interventions

DRUG

Capecitabine

DRUG

Oxaliplatin

RADIATION

Radiotherapy

Trial Locations (1)

325000

The First Affiliated Hospital of Wenzhou Medical College, Wenzhou

All Listed Sponsors

lead

xie congying

OTHER

NCT01711242 - Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma | Biotech Hunter | Biotech Hunter